AUS
NZ
UK
CA
USA
IND
Healthcare
Is FTSE 350 Stock Oxford Nanopore Technologies (LSE:ONT) Aligned With Sector Trends?
July 15, 2025 11:12 AM BST| By Team Kalkine MediaHighlights,Oxford Nanopore Technologies operates within the biotechnology segment of the pharmaceutical industry.,The company reports earnings that align closely with reported free cash flows.,Capital investment activity reflects a consistent approac...
Is FTSE 100 Healthcare Stock (LSE:SN) Drawing Market Attention Through Institutional Interest?
July 15, 2025 10:39 AM BST| By Team Kalkine MediaHighlights,Smith & Nephew is listed on the FTSE 100 and operates within the medical technology sector.,The company’s ownership structure includes significant institutional presence.,Broader healthcare sector activity continues amid global medical inf...
Is Eco Animal Health Group (LSE:EAH) Receiving Sector Focus in the FTSE AIM 100 Index?
July 15, 2025 09:20 AM BST| By Team Kalkine MediaHighlights,Eco Animal Health Group operates within the veterinary pharmaceutical sector and is listed on the FTSE AIM 100 Index.,The company received public coverage from a financial institution referencing its latest market performance.,The attentio...
Is RELX (FTSE 100) Signaling Market Momentum with Latest Share Price Shift?
July 15, 2025 06:00 AM BST| By Team Kalkine MediaHighlights,RELX share price moved above a key technical average.,Trading activity increased during the session compared to recent patterns.,Movement occurred while the FTSE 100 showed modest overall gains.,RELX (LSE:REL) operates within the informati...
Why FTSE 100: Is AstraZeneca Gaining Attention for Its Latest Immunotherapy Update?
July 15, 2025 05:06 AM BST| By Team Kalkine MediaHighlights,AstraZeneca disclosed new data from an immunotherapy-focused clinical trial.,The update involves combination treatments for patients with specific types of lung cancer.,Regulatory filings and presentations followed the release at a global...
Can Creo Medical Group PLC (LSE:CREO) Innovate Within the FTSE AIM UK 50 Medical Segment?
July 15, 2025 12:00 AM BST| By Team Kalkine MediaHighlights,Creo Medical develops advanced electrosurgical solutions for minimally invasive procedures.,The company’s technology platform supports energy-based applications in endoscopy.,FTSE AIM UK 50 comparison shows alignment in innovation and heal...
Is FTSE 100 Climbing Higher With AstraZeneca (LSE:AZN) at the Front?
July 14, 2025 12:00 AM BST| By Team Kalkine MediaAstraZeneca operates in the healthcare
FTSE 100: AstraZeneca Secures EU Approval – What It Means for LSE:AZN Stock?
July 07, 2025 07:51 PM BST| By Team Kalkine MediaHighlights,AstraZeneca received European Commission approval for a new cancer treatment.,The approval supports the company’s oncology product line in the European market.,AstraZeneca focuses on expanding treatment options across its pharmaceutical po...
How Is (LSE:AZN) AstraZeneca Advancing Bladder Cancer Therapy Within the FTSE 350 Framework?
July 04, 2025 12:00 AM BST| By Team Kalkine MediaHighlights,AstraZeneca gains European regulatory approval for Imfinzi in muscle-invasive bladder cancer.,The treatment includes perioperative administration, combining pre- and post-surgical delivery.,The development underlines AstraZeneca’s role wit...
How AstraZeneca (LSE:AZN) Influenced FTSE 100 Today Amid Broader Updates
July 04, 2025 12:00 AM BST| By Team Kalkine MediaHighlights,FTSE 100 today opened lower amid tariff-related updates and cross-border developments,AstraZeneca received European Union approval for a cancer treatment,Market sentiment across major European indices showed coordinated softness,The,FTSE 1...
FTSE AIM UK 50 Index: Why Abingdon Health (LSE:ABDX) Shares Moved Following Recent Updates?
July 03, 2025 10:26 AM BST| By Team Kalkine MediaHighlights:,Abingdon Health shares experienced movement.,The company operates within the medical diagnostics sector.,The company is listed on the FTSE AIM UK 50 Index.,Abingdon Health (LSE:ABDX), part of the,FTSE AIM UK 50 Index,, operates within the...
Convatec Group’s Performance in the FTSE 100 Healthcare Segment
June 27, 2025 05:20 PM BST| By Team Kalkine MediaHighlights,Convatec Group operates within the healthcare sector and is listed on the FTSE 100,The company's performance spans wound care, ostomy care, continence, and infusion devices,Continued momentum reported across business segments,Convatec Grou...
AstraZeneca (LSE:AZN) Gains FDA Nod for Datroway in Lung Cancer, Enhancing FTSE 100 Oncology Focus
June 26, 2025 05:17 PM BST| By Team Kalkine MediaHighlights,AstraZeneca secures FDA accelerated approval for Datroway in treating advanced EGFR-mutated non-small cell lung cancer,The company's share price remains steady despite recent positive regulatory developments,Ongoing advancements in oncolog...
Smith & Nephew’s Role in the FTSE 100 Healthcare Segment
June 25, 2025 02:41 PM BST| By Team Kalkine MediaHighlights,Smith & Nephew plc (LON:SN) operates within the healthcare sector under the FTSE 100,The company is known for orthopaedics, sports medicine, and wound management,Its operations span globally, with focus on innovation across surgical techno...
Tissue Regenix (LON:TRX) Strengthens Presence in FTSE AIM 100 Index
June 25, 2025 09:31 AM BST| By Team Kalkine MediaHighlights,Tissue Regenix Group PLC (LON:TRX) operates within the FTSE AIM 100 Index,Expanded distribution channels and tissue processing capacity in regenerative medical devices,San Antonio facility acquisition aligns with future scalability objecti...
Scancell Holdings (LON:SCLP) Advances Immunotherapy Trials in FTSE AIM
June 25, 2025 08:32 AM BST| By Team Kalkine MediaHighlights,Scancell Holdings PLC (LON:SCLP) is listed on the FTSE AIM UK 50 INDEX, operating in the biotechnology sector,The company is conducting a phase II trial for its iSCIB1+ cancer immunotherapy for advanced melanoma,Plans to spin off its GlyMa...
Datroway Boosts AstraZeneca’s Role in Lung Cancer Therapy | FTSE 100 Focus
June 24, 2025 03:30 PM BST| By Team Kalkine MediaHighlights,AstraZeneca PLC (LON:AZN), listed on the,FTSE 100,, gains FDA accelerated approval for Datroway in advanced lung cancer.,Datroway, an antibody-drug conjugate developed with Daiichi Sankyo, shows promise in treating non-small cell lung canc...
Polarean Imaging (LON:POLX) Expands US Reach with Strategic Agreement
June 24, 2025 01:30 PM BST| By Team Kalkine MediaHighlights,Polarean Imaging (LON:POLX) enters a commercial partnership with Ascend Imaging to enhance distribution in key US regions,The agreement supports the of Polarean’s xenon-based MRI technology without expanding internal headcount,Market respo...
Monument Therapeutics Advances CIAS Treatment in FTSE AIM Index
June 24, 2025 11:30 AM BST| By Team Kalkine MediaHighlights,Monument Therapeutics progresses in treating cognitive impairment in schizophrenia.,Cambridge Cognition (LON:COG) supports development through digital assessment tools.,Both firms are listed under the FTSE AIM UK 50 Index and FTSE AIM 100...
GlaxoSmithKline Maintains Pipeline Strength and Dividend Appeal | FTSE 100
June 24, 2025 11:29 AM BST| By Team Kalkine MediaHighlights,GlaxoSmithKline plc (LON:GSK) operates in the pharmaceuticals sector under the FTSE 100 and FTSE 350 indices,The company continues developing treatments across respiratory, HIV, and oncology portfolios,GSK is featured in the FTSE Dividend...
